PEGINESATIDE: 16 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
16
Total FAERS Reports
2 (12.5%)
Deaths Reported
8
Hospitalizations
16
As Primary/Secondary Suspect
1
Life-Threatening
Mar 27, 2012
FDA Approved
Discontinued
Status
FDA Application: 202799 ·
Patent Expires: Jun 2, 2026 · First Report: 201202 · Latest Report: 20160625
What Are the Most Common PEGINESATIDE Side Effects?
#1 Most Reported
Nausea
4 reports (25.0%)
#2 Most Reported
Dyspnoea
4 reports (25.0%)
#3 Most Reported
Urticaria
3 reports (18.8%)
All PEGINESATIDE Side Effects by Frequency
No side effect data available.
Who Reports PEGINESATIDE Side Effects? Age & Gender Data
Gender: 61.5% female, 38.5% male. Average age: 65.4 years. Most reports from: US. View detailed demographics →
Is PEGINESATIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 4 | 0 | 1 |
| 2013 | 7 | 0 | 2 |
| 2014 | 2 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
What Is PEGINESATIDE Used For?
| Indication | Reports |
|---|---|
| Nephrogenic anaemia | 11 |
Official FDA Label for PEGINESATIDE
Official prescribing information from the FDA-approved drug label.